JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120413

A 438079, competitive P2X7 receptor antagonist

Be the first to review this product! Submit a review

|

(4 Publications)

MW 342.6 Da, Purity >98%. Potent, competitive P2X7 receptor antagonist (pIC50 = 6.5 nM). Shown to reduce pathological nociception.
1 Images
Chemical Structure - A 438079, competitive P2X7 receptor antagonist (AB120413)
  • Chemical Structure

Lab

Chemical Structure - A 438079, competitive P2X7 receptor antagonist (AB120413)

2D chemical structure image of ab120413, A 438079, competitive P2X7 receptor antagonist

Key facts

CAS number

899431-18-6

Purity

>98%

Form

Solid

form

Molecular weight

342.6 Da

Molecular formula

C<sub>1</sub><sub>3</sub>H<sub>1</sub><sub>0</sub>Cl<sub>3</sub>N<sub>5</sub>

PubChem

11688742

Nature

Synthetic

Solubility

Soluble in DMSO to 100 mM

Soluble in water to 5 mM

Biochemical name

A 438079 hydrochloride

Biological description

Potent, competitive P2X7 receptor antagonist (pIC50 = 6.5 nM). Shown to reduce pathological nociception.

Canonical smiles

C1=CC(=C(C(=C1)Cl)Cl)C2=NN=NN2CC3=CN=CC=C3.Cl

InChi

InChI=1S/C13H9Cl2N5.ClH/c14-11-5-1-4-10(12(11)15)13-17-18-19-20(13)8-9-3-2-6-16-7-9;/h1-7H,8H2;1H

InChiKey

MBTJFFMIPPMRGR-UHFFFAOYSA-N

IUPAC Name

3-[[5-(2,3-dichlorophenyl)tetrazol-1-yl]methyl]pyridine;hydrochloride

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Product protocols

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Cancer immunology research 10:871-884 PubMed35588154

2022

P2RX7 Enhances Tumor Control by CD8+ T Cells in Adoptive Cell Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Kelsey M Wanhainen,Changwei Peng,Maggie H Zhou,Bruna de Gois Macedo,Stephen O'Flanagan,Tingyuan Yang,Ameeta Kelekar,Brandon J Burbach,Henrique Borges da Silva,Stephen C Jameson

International journal of molecular medicine 49: PubMed35266010

2022

Potential mechanisms of osteoprotegerin-induced damage to osteoclast adhesion structures via P2X7R-mediated MAPK signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Yonggang Ma,Xueni Shi,Hongyan Zhao,Ruilong Song,Hui Zou,Jiaqiao Zhu,Zongping Liu

Toxicology letters 333:22-32 PubMed32721574

2020

P2X7R orchestrates the progression of murine hepatic fibrosis by making a feedback loop from macrophage to hepatic stellate cells.

Applications

Unspecified application

Species

Unspecified reactive species

Min Jiang,Ben-Wen Cui,Yan-Ling Wu,Yu Zhang,Yue Shang,Jian Liu,Hong-Xu Yang,Chun-Ying Qiao,Zi-Ying Zhan,Huan Ye,Quan Jin,Ji-Xing Nan,Li-Hua Lian

International journal of molecular sciences 18: PubMed29077063

2017

P2X4 Receptor-Dependent Ca Influx in Model Human Monocytes and Macrophages.

Applications

Unspecified application

Species

Unspecified reactive species

Janice A Layhadi,Samuel J Fountain
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com